Endothelial protection by pentaerithrityl trinitrate: Bilirubin and carbon monoxide as possible mediators

Experimental Biology and Medicine

Volumn 228, Issue 5, 2003, Pages 529-534

  Oberle, Stefanie ^a   Abate, Aida ^a   Grosser, Nina ^a   Hemmerle, Anke ^a   Vreman, Hendrik J ^b   Dennery, Phyllis A ^b   Schneider, Heinz T ^c   Stalleicken, Dirk ^c   Schröder, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBSTADT SIGMARINGEN UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Cell proliferation; Nitric oxide; Oxidative stress

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; HEME OXYGENASE 1; PENTAERYTHRITYL TETRANITRATE; PENTAERYTHRITYL TRINITRATE; UNCLASSIFIED DRUG; ANTIOXIDANT; DRUG DERIVATIVE; HEME OXYGENASE; HMOX1 PROTEIN, HUMAN; ISOSORBIDE DINITRATE; MEMBRANE PROTEIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PENTRINITROL;

ANTIOXIDANT ACTIVITY; ARTERY ENDOTHELIUM; ATHEROSCLEROSIS; CATALYSIS; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM; ENDOTHELIUM CELL; GAS CHROMATOGRAPHY; PROTEIN EXPRESSION; PROTEIN ISOLATION; VIDEODENSITOMETRY; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; BILIRUBIN; CARBON MONOXIDE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; ISOSORBIDE DINITRATE; MEMBRANE PROTEINS; NITRIC OXIDE DONORS; PENTAERYTHRITOL TETRANITRATE; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 0038545209     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/15353702-0322805-21     Document Type: Conference Paper

References (43)

1. Schröder H, Leitman DC, Bennett BM, Waldman SA, Murad F. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther 245:413-418, 1988.
2. Harrison DG, Bates JN. The nitrovasodilators new ideas about old drugs. Circulation 87:1461-1467, 1993.
3. Feelisch M, Stamler JS. Donors of nitrogen oxides. In: Feelisch M, Stamler JS, Eds. Methods in Nitric Oxide Research. Chichester, NY: John Wiley & Sons Ltd, pp71-115, 1996.
4. Crandall LA Jr, Leake CD, Loevenhart AS, Muehlberger CW. Acquired tolerance and cross tolerance between the nitrous and nitric acid and sodium nitrate in man. J Pharmacol Exp Ther 41:103-120, 1931.
5. Bogaert MG, De Schaepdryver AF. Tolerance towards glyceryl trinitrate (trinitrin) in dogs. Arch Int Pharmacodyn Ther 171:221-224, 1968.
6. Münzel T, Sayegh H, Freeman A, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest 95:187-194, 1995.
7. Münzel T, Harrison DG. Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance. J Mol Med 75:891-900, 1997.
8. Fink B, Bassenge E. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate. J Cardiovasc Pharmacol 30:831-836, 1997.
9. Dikalov S, Fink B, Skatchkov M, Stalleicken D, Bassenge E. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrite in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 286:938-944, 1998.
10. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: A human in vivo study. J Am Coll Cardiol 38:854-859, 2001.
11. Kojda G, Hacker A, Noack E. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production. Eur J Pharmacol 355:23-31, 1998.
12. Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J Cardiovasc Pharmacol 25:763-773, 1995.
13. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996.
14. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997.
15. Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 60:1121-1128, 2000.
16. Suttner DM, Sridhar K, Lee CS, Tomura T, Hansen TN, Dennery PA. Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells. Am J Physiol 276:L443-L451, 1999.
17. Yang L, Quan S, Abraham NG. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol 277:L127-L133, 1999.
18. Polte T, Abate A, Dennery PA, Schröder H. Heme oxygenase-1 is a cyclic GMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 20:1209-1215, 2000.
19. Polte T, Hemmerle A, Grosser N, Abate A, Schröder H. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: Role of cGMP and heme oxygenase-1. Free Radic Biol Med 32:56-63, 2001.
20. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046, 1987.
21. Coceani F. Carbon monoxide in vasoregulation. Circ Res 86:1184-1186, 2000.
22. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86:99-103, 1998.
23. Suda K, Rothen-Rutishauser B, Gunthert M, Wunderli-Allenspach H. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: Endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 37:505-514, 2001.
24. Oberle S, Schröder H. Ferritin may mediate SIN-1-induced protection against oxidative stress. Nitric Oxide 1:308-314, 1997.
25. Oberle S, Polte T, Abate A, Podhaisky H-P, Schröder H. Aspirin increases ferritin synthesis in endothelial cells: A novel antioxidant pathway. Circ Res 82:1016-1020, 1998.
26. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 259:523-526, 1999.
27. Abate A, Yang G, Dennery PA, Oberle S, Schröder H. Synergistic inhibition of cyclooxygenase-2 by vitamin E and aspirin. Free Radic Biol Med 29:1135-1142, 2000.
28. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270:H107-H114, 1996.
29. Vreman HJ, Stevenson DK. Heme oxygenase activity as measured by carbon monoxide production. Anal Biochem 168:31-38, 1988.
30. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167-175, 1984.
31. Hacker A, Muller S, Meyer W, Kojda G. The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. Br J Pharmacol 132:1707-1714, 2001.
32. Hinz B, Kuntze U, Schröder H. Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation. Biochem Biophys Res Commun 253:658-661, 1998.
33. Crew MC, Gala RL, Haynes LJ, Di Carlo FJ. Biliary excretion and biotransformation of pentaerythritol trinitrate in rats. Biochem Pharmacol 20:3077-3089, 1971.
34. Weber W, Michaelis K, Luckow V, Kuntze U, Stalleicken D. Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites. Drug Res 45:781-784, 1995.
35. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103:129-135, 1999.
36. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16:250-255, 1996.
37. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46:1723-1727, 2000.
38. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, Davis RJ, Flavell RA, Choi AMK. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428, 2000.
39. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AMK, Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1025, 2000.
40. Oberle S, Schwartz P, Abate A, Schröder H. The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate. Biochem Biophys Res Commun 261:28-34, 1999.
41. Schröder H, Leitman DC, Hayward LD, Bennett BM, Murad F. Cultured rat lung fibroblasts as a model for organic nitrate-induced cyclic GMP accumulation and activation of guanylate cyclase. J Appl Cardiol 2:301-311, 1987.
42. Weber AA, Strobach H, Schrör K. Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 247:29-37, 1993.
43. Abrams J. The role of nitrates in coronary heart disease. Arch Intern Med 155:357-364, 1995.